10x Genomics, Inc. (TXG)

NMS – Real Time Price. Currency in USD

57.92

-0.56 (-0.95%)

Market open: Aug 12, 2026, 10:46 AM EDT

58.47

-0.01 (-0.02%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

07.08.2026

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.

07.08.2026

10x Genomics Q2 Earnings Call Highlights

10x Genomics NASDAQ: TXG reported second-quarter revenue of $151 million, including $1.6 million in license and royalty revenue tied to its settlement with Takara. Excluding non-recurring settlement revenue in both periods, revenue was $149.4 million, up 3% from a year earlier.

07.08.2026

10x Genomics, Inc. (TXG) Q2 2026 Earnings Call Transcript

06.08.2026

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for 10x Genomics (TXG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

06.08.2026

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.28 per share a year ago.

06.08.2026

10x Genomics Reports Second Quarter 2026 Financial Results

PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today reported financial results for the second quarter ended June 30, 2026.

04.08.2026

10x Genomics (TXG) Upgraded to Buy: Here's Why

10x Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Videos

No Data

There is no data to display

Press releases

06.08.2026

10x Genomics, Inc. (TXG)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

10x Genomics, Inc. (TXG)

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics Q2 Earnings Call Highlights

10x Genomics, Inc. (TXG) Q2 2026 Earnings Call Transcript

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics Reports Second Quarter 2026 Financial Results

10x Genomics (TXG) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

10x Genomics Reports Second Quarter 2026 Financial Results

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics Q2 Earnings Call Highlights

10x Genomics, Inc. (TXG) Q2 2026 Earnings Call Transcript

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics Reports Second Quarter 2026 Financial Results

10x Genomics (TXG) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

10x Genomics Reports Second Quarter 2026 Financial Results

Search stocks

10x Genomics, Inc. (TXG)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

10x Genomics, Inc. (TXG)

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics Q2 Earnings Call Highlights

10x Genomics, Inc. (TXG) Q2 2026 Earnings Call Transcript

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics Reports Second Quarter 2026 Financial Results

10x Genomics (TXG) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

10x Genomics Reports Second Quarter 2026 Financial Results

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics Q2 Earnings Call Highlights

10x Genomics, Inc. (TXG) Q2 2026 Earnings Call Transcript

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics Reports Second Quarter 2026 Financial Results

10x Genomics (TXG) Upgraded to Buy: Here's Why

Videos

No Data

Press releases

10x Genomics Reports Second Quarter 2026 Financial Results